IP Library Granted Patent US 8,883,423
Granted Patent B2
US 8,883,423 · App. 13/649,839 · Granted Nov 11, 2014

NMR systems and methods for the rapid detection of analytes

Inventor: Lori A. Neely (Reading, MA)
Assignee: T2 Biosystems, Inc.
G01N27/745G01R33/448G01R33/302C12Q1/6895G01R33/465G01N24/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,423
App. No.
13/649,839
Granted
Nov 11, 2014
Kind
B2
Abstract

This invention features systems and methods for the detection of analytes, and their use in the treatment and diagnosis of disease.

Claims (34)

1. A method for making a Candida amplicon, said method comprising amplifying by polymerase chain reaction a Candida nucleic acid from a Candida species in the presence of a forward primer and a reverse primer to produce the Candida amplicon,

wherein the forward primer consists of the oligonucleotide sequence 5′-GGC ATG CCT GTT TGA GCG TC-3′ (SEQ ID NO:1), and the reverse primer consists of the oligonucleotide sequence 5′-GCT TAT TGA TAT GCT TAA GTT CAG CGG GT-3′ (SEQ ID NO:2).

2. The method of claim 1 , wherein the Candida species is Candida albicans , and wherein the method further comprises detecting the Candida amplicon by hybridizing the amplicon with an oligonucleotide comprising a sequence selected from the group consisting of:

5′-ACC CAG CGG TTT GAG GGA GAA AC-3′ (SEQ ID NO: 3),

and

5′-AAA GTT TGA AGA TAT ACG TGG TGG ACG TTA-3′ (SEQ ID NO:4).

3. The method of claim 1 , wherein the Candida species is Candida krusei , and wherein the method further comprises detecting the Candida amplicon by hybridizing the amplicon with an oligonucleotide comprising a sequence selected from the group consisting of:

(SEQ ID NO. 5)

5′-CGC ACG CGC AAG ATG GAA ACG-3′,

(SEQ ID NO. 6)

5′-AAG TTC AGC GGG TAT TCC TAC CT-3′,

and

(SEQ ID NO. 32)

5′-AGC TTT TTG TTG TCT CGC AAC ACT CGC-3′.

4. The method of claim 1 , wherein the Candida species is Candida glabrata , and wherein the method further comprises detecting the Candida amplicon by hybridizing the amplicon with an oligonucleotide comprising a sequence selected from the group consisting of:

(SEQ ID NO: 7)

5′-CTA CCA AAC ACA ATG TGT TTG AGA AG-3′

and

(SEQ ID NO: 8)

5′-CCT GAT TTG AGG TCA AAC TTA AAG ACG TCT G-3′.

5. The method of claim 1 , wherein the Candida species is Candida parapsilosis or Candida tropicalis , and wherein the method further comprises detecting the Candida amplicon by hybridizing the amplicon with an oligonucleotide comprising a sequence selected from the group consisting of:

(SEQ ID NO: 9)

5′-AGT CCT ACC TGA TTT GAG GTCNitIndAA-3′,

(SEQ ID NO: 10)

5′-CCG NitIndGG GTT TGA GGG AGA AAT-3′,

(SEQ ID NO: 33)

5′-AAA GTT ATG AAATAA ATT GTG GTG GCC ACT AGC-3′,

(SEQ ID NO: 34)

5′-ACC CGG GGGTTT GAG GGA GAA A-3′,

(SEQ ID NO: 35)

5′-AGT CCT ACC TGA TTT GAG GTC GAA-3′,

and

(SEQ ID NO: 36)

5′-CCG AGG GTT TGA GGG AGA AAT-3′.

Assignments (2)
SECURITY INTEREST Recorded Dec 30, 2016
From: T2 BIOSYSTEMS, INC.
To: CRG SERVICING LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 041226/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2012
From: NEELY, LORI ANNE; AUDEH, MARK JOHN; DHANDA, RAHUL; FRITZEMEIER, MARILYN LEE; PLOURDE, DANIELLA LYNN; RITTERSHAUS, CHARLES WILLIAM
To: T2 BIOSYSTEMS, INC.
Reel/Frame 029145/0615 →
Continuity (9)
Continuation 13646402 · Oct 5, 2012
Division 13402566 · Feb 22, 2012
Continuation 13363916 · Feb 1, 2012
Continuation 13384051
Continuation In Part 12910594 · Oct 22, 2010
Provisional Application 61414141 · Nov 16, 2010
Provisional Application 61418465 · Dec 1, 2010
Provisional Application 61497374 · Jun 15, 2011
Related Publication 20130095494A1 · Apr 18, 2013